Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kahn

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Journal of the Massachusetts Dental Society|August 30, 2006
A clinico-pathologic correlation. Aggressive fibromatosis and peripheral ossifying fibromaNicholas Bauter, Richard D'Innocenzo, Michael Kahn
Combinatorial Chemistry & High Throughput Screening|February 20, 2007
High-throughput nanoparticle catalysis: partial oxidation of propyleneShici Duan, Michael Kahn, Selim Senkan
Proceedings. AMIA Symposium|December 5, 2002
Temporal knowledge representation for scheduling tasks in clinical trial protocolsChunhua Weng, Michael Kahn, John Gennari
Handbook of Experimental Pharmacology|August 31, 2021
Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of DamoclesKeane K Y Lai, Michael Kahn
Cancer Drug Resistance (Alhambra, Calif.)|May 20, 2020
Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistanceAndrea Bild, Jia-Ling Teo, Michael Kahn
Stem Cell Reviews and Reports|May 24, 2011
Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogrammingToshio Miki, Shin-ya Yasuda, Michael Kahn
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2017
Pharmacologic Manipulation of Wnt Signaling and Cancer Stem CellsYann Duchartre, Yong-Mi Kim, Michael Kahn
Expert Opinion on Therapeutic Targets|April 8, 2014
The potential of targeting Wnt/β-catenin in colon cancerAna Sebio, Michael Kahn, Heinz-Josef Lenz
Medical Care|June 25, 2013
Data quality assessment for comparative effectiveness research in distributed data networksJeffrey S Brown, Michael Kahn, Sengwee Toh
Critical Reviews in Oncology/Hematology|January 19, 2016
The Wnt signaling pathway in cancerYann Duchartre, Yong-Mi Kim, Michael Kahn
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Journal of the Massachusetts Dental Society|August 30, 2006
A clinico-pathologic correlation. Aggressive fibromatosis and peripheral ossifying fibromaNicholas Bauter, Richard D'Innocenzo, Michael Kahn
Combinatorial Chemistry & High Throughput Screening|February 20, 2007
High-throughput nanoparticle catalysis: partial oxidation of propyleneShici Duan, Michael Kahn, Selim Senkan
Proceedings. AMIA Symposium|December 5, 2002
Temporal knowledge representation for scheduling tasks in clinical trial protocolsChunhua Weng, Michael Kahn, John Gennari
Handbook of Experimental Pharmacology|August 31, 2021
Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of DamoclesKeane K Y Lai, Michael Kahn
Cancer Drug Resistance (Alhambra, Calif.)|May 20, 2020
Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistanceAndrea Bild, Jia-Ling Teo, Michael Kahn
Stem Cell Reviews and Reports|May 24, 2011
Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogrammingToshio Miki, Shin-ya Yasuda, Michael Kahn
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2017
Pharmacologic Manipulation of Wnt Signaling and Cancer Stem CellsYann Duchartre, Yong-Mi Kim, Michael Kahn
Expert Opinion on Therapeutic Targets|April 8, 2014
The potential of targeting Wnt/β-catenin in colon cancerAna Sebio, Michael Kahn, Heinz-Josef Lenz
Medical Care|June 25, 2013
Data quality assessment for comparative effectiveness research in distributed data networksJeffrey S Brown, Michael Kahn, Sengwee Toh
Critical Reviews in Oncology/Hematology|January 19, 2016
The Wnt signaling pathway in cancerYann Duchartre, Yong-Mi Kim, Michael Kahn
Pageof 14